SomnoMed Ltd (FRA:RJV)
€ 0.16 -0.006 (-3.61%) Market Cap: 38.09 Mil Enterprise Value: 32.24 Mil PE Ratio: 0 PB Ratio: 1.34 GF Score: 53/100

Full Year 2022 Somnomed Ltd Earnings Call Transcript

Aug 23, 2022 / 03:00AM GMT
Release Date Price: €0.685907 (+4.62%)
Operator

Hi, and welcome to SomnoMed Limited FY '22 Results Conference Call. (Operator Instructions) There will be a presentation followed by a question-and-answer session. (Operator Instructions) I would now like to hand the conference over to Mr. Neil Verdal-Austin, CEO. Please go ahead.

Neil Verdal;Austin
SomnoMed Limited - Global CEO, MD & Director

Thank you, Rachel. Good afternoon, ladies and gentlemen. Welcome to SomnoMed's webcast and investor presentation of the FY '22 results. And thank you very much for your time today.

FY '22 certainly remained a challenge from a COVID perspective, not only for SomnoMed, of course, but for everyone around the world. We are now, hopefully, towards the end of this global pandemic and have now probably entered into a sort of a managed phase of this, but have also now, unfortunately, entered another period of uncertainty around the global economic climate, adding supply chain issues, inflationary pressures and rising costs to the running of businesses around the world. But having said that, SomnoMed

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot